Yamamoto Kei | Department Of Geriatric Medicine Osaka University Medical School

スポンサーリンク

概要

関連著者

もっと見る

著作論文

A Family with Von Hippel-Lindau Disease Revealed by Pheochromocytoma
Effect of E2F decoy on inhibitation of neointima formation in pig coronary arteries after balloon injury and stent implantation
Contribution of a Vascular Modulator, Hepatocyte Growth factor (HGF), to the Pathogenesis of Cardiovascular Disease
FRS-013 Long Term Evaluation of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Angiogenesis and Regeneration Medicine in Cardiovascular Medicine (M) : FRS3)(Featured Research Session (Engl
Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor
Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin 12 Analogue) in the Porcine Coronary Artery after Angioplasty
Results of Safety from Human Clinical Gene Therapy Using HGF (TREAT-HGF)
Long Term Evaluation of Results from the First Stage in the Clinical Trial of Gene Therapy for Peripheral Arterial Disease
Clinical Results of TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer)
Evaluation of utility of prostagrandin E1 in the patients with ASO : Protective effect on endothelial function through up-regulation of HGF
No increase in human HGF concentration in the patients transfected with human HGF plasmid : preliminary clinical results from TREAT-HGF
Preliminary clinical results from TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using HGF Gene Transfer)
Preliminary clinical results from TREAT-HGF : Gene therapy for PAD
Therapeutic Angiogenesis Induced by Transfection of Hepatocyte Growth Factor (HGF) Gene in Porcine Myocardial Infarction Model
Novel Molecular Therapeutic Approach to Cardiovascular Disease Based on Hepatocyte Growth Factor (HGF)
PJ-341 Acceleration of wound healing by combination gene transfer of Hepatocyte Growth Factor and Prostacyclin Synthase with Shima Jet(Peripheral Circulation/Vascular Disease 3(H) : PJ57)(Poster Session (Japanese))
Novel Therapeutic Approach Using siRNA to Reduce Plasama High Concentration of Lp(a)(Lipid Disorders 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Therapeutic Potential of a Novel Ribbon-type Decoy Oligonucleotides for Vascular Diseases(Molecular Biology, Vascular 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
PJ-278 Important Role of Nuclear Factor-κ(NF κB) in Neointimal Formation in Porcine Balloon Injury Model(Infection/Inflammation/Immunity 3 (H) : PJ47)(Poster Session (Japanese))
PJ-091 Improvement of Diabetic Neuropathy by HGF Gene Transfer(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
PJ-089 Potential of Novel Ribbon-type E2F Decoy in vivo Neointimal Hyperplasia(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
OJ-529 Ribozyme Oligonucleotides Against TGF-Beta Transferred by Ultrasound Inhibited the Progression of Diseases in Anti-Thy1 Model(Kidney/Renal Circulation 3 (H) : OJ65)(Oral Presentation (Japanese))
OJ-377 Combination Therapy by ACEI and ARB on vascular remodeling in a porcine coronary artery injury model(Restenosis after Angioplasty, Basic/Clinical 3 (IHD) : OJ46)(Oral Presentation (Japanese))

もっと見る

スポンサーリンク